1. |
Berger B, Hottenrott T, Rauer S, et al. Screening for onconeural antibodies in neuromyelitis optica spectrum disorders. BMC Neurol, 2017, 17(1): 5.
|
2. |
Geis C, Weishaupt A, Hallermann S, et al. Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain, 2010, 133(11): 3166-3180.
|
3. |
TakeiK, Slepnev VI, Haucke V, et al. Functional partnership between amphiphysin and dynamin in clathrin-mediated endocytosis. Nat Cell Biol, 1999, 1(1): 33-39.
|
4. |
Nayak L, Rubin M. Amphiphysin autoimmunity in paraneoplastic neurologic disease. Clin Adv Hematol Oncol, 2009, 7(3): 183-184.
|
5. |
Lichte B, Veh RW, Meyer HE, et al. Amphiphysin, a novel protein associated with synaptic vesicles. EMBO J, 1992, 11(7): 2521-2530.
|
6. |
Faissner S, Lukas C, Reinacher-Schick A, et al. Amphiphysin-positive paraneoplastic myelitis and stiff-person syndrome. Neurol Neuroimmunol Neuroinflamm, 2016, 3(6): e285.
|
7. |
Krishna VR, Knievel K, Ladha S, et al. Lower extremity predominant stiff-person syndrome and limbic encephalitis with amphiphysin antibodies in breast cancer. J Clin Neuromuscul Dis, 2012, 14(2): 72-74.
|
8. |
Neshige S, Hara N, Takeshima S, et al. Anti-amphiphysin antibody-positive paraneoplastic neurological syndrome with a longitudinally extensive spinal cord lesion of the dorsal column. Rinsho Shinkeigaku, 2014, 54(7): 572-576.
|
9. |
Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev, 2017, 97(2): 839-887.
|
10. |
Galassi G, Ariatti A, Rovati R, et al. Longitudinally extensive transverse myelitis associated with amphiphysin autoimmunity and breast cancer: a paraneoplastic accompaniment. Acta Neurol Belg, 2016, 116(3): 395-397.
|
11. |
Wagner-Altendorf TA, Wandinger KP, Frydrychowicz A, et al. Anti-amphiphysin-associated limbic encephalitis in a 72-year-old patient with aortic angiosarcoma. BMJ Case Rep, 2019, 12(3): e226798.
|
12. |
Dubey D, Jitprapaikulsan J, Bi H, et al. Amphiphysin-IgG autoimmune neuropathy: a recognizable clinicopathologic syndrome. Neurology, 2019, 93(20): e1873-e1880.
|
13. |
乔雷, 关鸿志, 任海涛, 等. 抗 amphiphysin 抗体相关副肿瘤神经综合征临床研究. 中华神经科杂志, 2016, 49(10): 769-774.
|
14. |
Grativvol RS, Cavalcante WCP, Castro LHM, et al. Updates in the diagnosis and treatment of paraneoplastic neurologic syndromes. Curr Oncol Rep, 2018, 20(11): 92.
|
15. |
Rosenfeld MR, Dalmau J. Diagnosis and management of paraneoplastic neurologic disorders. Curr Treat Options Oncol, 2013, 14(4): 528-538.
|
16. |
Pittock SJ, Palace J. Paraneoplastic and idiopathic autoimmune neurologic disorders: approach to diagnosis and treatment. Handb Clin Neurol, 2016, 133: 165-183.
|
17. |
周立新, 关鸿志, 刘洪生, 等. 小细胞肺癌相关神经副肿瘤综合征的临床特点及治疗. 中华医学杂志, 2015, 95(37): 3023-3026.
|
18. |
Rosenfeld MR, Dalmau J. Paraneoplastic neurologic syndromes. Neurol Clin, 2018, 36(3): 675-685.
|
19. |
Yau GS, Lee JW, Chan TT, et al. Neuromyelitis optica spectrum disorder in a chinese woman with ocular myasthenia gravis: first reported case in the chinese population. Neuroophthalmology, 2014, 38(3): 140-144.
|
20. |
McKeon A, Lennon VA, Jacob A, et al. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve, 2009, 39(1): 87-90.
|
21. |
Bibic VC, Brust TB, Burton JM. Neuromyelitis optica spectrum disorder presenting with concurrent autoimmune diseases. Mult Scler Relat Disord, 2019, 28: 125-128.
|